| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/07/2011 | US20110166175 7-azaindole derivatives |
| 07/07/2011 | US20110166172 Rapamycin Carbonic Ester Analogues, Pharmaceutical Compositions, Preparations and Uses Thereof |
| 07/07/2011 | US20110166170 Synthesis of avrainvillamide, stephacidin b, and analogues thereof |
| 07/07/2011 | US20110166169 Novel hsp90 inhibitory carbazole derivatives, compositions containing same and use thereof |
| 07/07/2011 | US20110166154 Identification of predictive markers of response to dasatinib in human colon cancer |
| 07/07/2011 | US20110166144 Pyrimidotriazinediones and Pyrimidopyrimidinediones and Methods of Using the Same |
| 07/07/2011 | US20110166141 Cathepsin s inhibitors |
| 07/07/2011 | US20110166140 Novel sulphonylpyrroles |
| 07/07/2011 | US20110166139 Pyridine compounds |
| 07/07/2011 | US20110166138 Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase for Modulation of Cannabinoid Receptors |
| 07/07/2011 | US20110166137 Substituted Naphthalenyl-Pyrimidine Compounds |
| 07/07/2011 | US20110166133 Fused nitrogen containing heterocycles and compositions thereof as kinase inhibitors |
| 07/07/2011 | US20110166129 Inhibitors of janus kinases |
| 07/07/2011 | US20110166127 Substituted Benzo-Pyrimido-Tetrazolo-Diazepine Compounds |
| 07/07/2011 | US20110166125 Substituted amides, manufacturing and use thereof as medicaments |
| 07/07/2011 | US20110166122 SUBSTITUTED IMIDAZO[1,2b]PYRIDAZINE COMPOUNDS AS TRK KINASE INHIBITORS |
| 07/07/2011 | US20110166120 Sulfonyl amide derivatives for the treatment of abnormal cell growth |
| 07/07/2011 | US20110166112 Method for stimulating platelet production |
| 07/07/2011 | US20110166108 Methods of use related to xerostomia |
| 07/07/2011 | US20110166104 Boron-containing small molecules |
| 07/07/2011 | US20110166102 Novel 2-substituted benzimidazoles as selective androgen receptor modulators (sarms) |
| 07/07/2011 | US20110166096 Uracil derivatives and use thereof |
| 07/07/2011 | US20110166095 Cancer platinum resistance detection and sensitization method |
| 07/07/2011 | US20110166094 Agonists of a2a adenosine receptors for treating recurrent tumor growth |
| 07/07/2011 | US20110166093 Use of adenosine receptor agonists in therapy |
| 07/07/2011 | US20110166092 Dosing methods for treating disease |
| 07/07/2011 | US20110166084 Controlled release composition and method of producing the same |
| 07/07/2011 | US20110166079 Methods of treating cancer with apoe peptides |
| 07/07/2011 | US20110166078 Oligosaccharide compounds for use in mobilising stem cells |
| 07/07/2011 | US20110166077 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy |
| 07/07/2011 | US20110166072 Polypeptides Selective for avB3 Integrin, Including Pegylated Polypeptides, And Pharmaceutical Uses Thereof |
| 07/07/2011 | US20110166058 Organic compositions to treat hsf1-related diseases |
| 07/07/2011 | US20110165659 Biological products |
| 07/07/2011 | US20110165653 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities |
| 07/07/2011 | US20110165633 Production of Polyketides and Other Natural Products |
| 07/07/2011 | US20110165599 Monoclonal antibody therapy for pancreas cancer |
| 07/07/2011 | US20110165271 Antitumoral terpenoid pharmaceutical composition 'abisilin' exhibiting angiogenesis-inhibiting action |
| 07/07/2011 | US20110165265 Trail variants for treating cancer |
| 07/07/2011 | US20110165259 Composite organic compound powder for medical use, method for producing same and suspension of same |
| 07/07/2011 | US20110165258 Polymeric delivery systems for active agents |
| 07/07/2011 | US20110165257 Coated drug spheroids and uses thereof for eliminating or reducing conditions such as emesis and diarrhea |
| 07/07/2011 | US20110165256 Compositions and methods for treatment of hyperplasia |
| 07/07/2011 | US20110165255 Malignant tumor heat therapy kit comprising anti-regulatory t cell antibody and magnetic fine particles and heat therapy method thereof |
| 07/07/2011 | US20110165251 Liquid dosage compositions of stable nanoparticulate active agents |
| 07/07/2011 | US20110165250 Compositions and methods for treatment of neoplastic disease |
| 07/07/2011 | US20110165243 Concurrent delivery of multiple therapeutic agents via hydrogels for biomedical applications |
| 07/07/2011 | US20110165227 Compositions and Methods Using siRNA Molecules for Treatment of Gliomas |
| 07/07/2011 | US20110165223 Antitumor Immunization by Liposomal Delivery of Vaccine to the Spleen |
| 07/07/2011 | US20110165201 Anticancer formulation |
| 07/07/2011 | US20110165197 Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines |
| 07/07/2011 | US20110165188 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 07/07/2011 | US20110165187 Tumor cells from immune privileged sites as base cells for cell-based cancer vaccines |
| 07/07/2011 | US20110165184 Cdh3 peptide and medicinal agent comprising the same |
| 07/07/2011 | US20110165180 Polypeptides capable of binding to CD64 comprising one or more heterologous T cell epitopes and their uses |
| 07/07/2011 | US20110165179 Therapeutic agents for alzheimer's disease and cancer |
| 07/07/2011 | US20110165170 Osteopontin antibodies |
| 07/07/2011 | US20110165166 Lsr receptor, its activity, its cloning, and its applications to the diagnosis, prevention and/or treatment of obesity and related risks or complications |
| 07/07/2011 | US20110165164 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors |
| 07/07/2011 | US20110165162 Methods for Treating Cancers Comprising K-ras Mutations |
| 07/07/2011 | US20110165161 Anti-epcam antibodies that induce apoptosis of cancer cells and methods using same |
| 07/07/2011 | US20110165160 Neutrokine-alpha and neutrokine-alpha splice variant |
| 07/07/2011 | US20110165159 Use of chimeric anti-cd20 antibody as in vitro or in vivo purging agent in patients receiving bmt or pbsc transplant |
| 07/07/2011 | US20110165157 Extending time to disease progression or survival in cancer patients |
| 07/07/2011 | US20110165156 Antibodies against human csf-1r and uses thereof |
| 07/07/2011 | US20110165155 Methods of treating metastatic breast cancer with trastuzumab-mcc-dm1 |
| 07/07/2011 | US20110165154 Compositions and methods using anti-cs1 antibodies to treat multiple myeloma |
| 07/07/2011 | US20110165153 Anti cd37 antibodies |
| 07/07/2011 | US20110165152 Combination therapy of an afucosylated cd20 antibody with fludarabine and/or mitoxantrone |
| 07/07/2011 | US20110165151 Combination therapy of an afucosylated cd20 antibody with bendamustine |
| 07/07/2011 | US20110165150 Isolated organ perfusion combination therapy of cancer |
| 07/07/2011 | US20110165149 Targeting abcb5 for cancer therapy |
| 07/07/2011 | US20110165148 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer |
| 07/07/2011 | US20110165145 Igf-ii/igf-iie binding proteins |
| 07/07/2011 | US20110165143 Modulation of caspases and therapeutical applications |
| 07/07/2011 | US20110165141 Compositions for treating bacterial infections |
| 07/07/2011 | US20110165137 Suppression of cancers |
| 07/07/2011 | US20110165134 Lactobacillus sp. jnu2116 with antimutagenic activity |
| 07/07/2011 | US20110165123 5' triphosphate oligonucleotide with blunt end and uses thereof |
| 07/07/2011 | US20110165117 Immunogenic peptides and methods of use |
| 07/07/2011 | US20110165116 Pharmaceutical compositions comprising ccl2 and use of same for the treatment of inflammation |
| 07/07/2011 | US20110165096 Ficus Extracts Having Angiogenesis Ihibiting Activity And Methods Of Isolating And using The Same |
| 07/07/2011 | US20110165081 Psma antibodies and uses thereof |
| 07/07/2011 | US20110165077 In vivo tumor targeting and spectroscopic detection with surface enhanced raman nanoparticle tags |
| 07/07/2011 | US20110165073 Immunotherapy of b-cell malignancies using anti-cd22 antibodies |
| 07/07/2011 | US20110165071 Methods Of Treating Cancer |
| 07/07/2011 | US20110165070 Methods for radiolabeling synthetic polymers |
| 07/07/2011 | US20110165069 Methods for radiolabeling macromolecules |
| 07/07/2011 | US20110165067 Carbohydrate functionalized catanionic surfactant vesicles for drug delivery |
| 07/07/2011 | US20110165065 Means for the detection and treatment of prostate cells |
| 07/07/2011 | US20110165064 Methods and compositions related to clot-binding compounds |
| 07/07/2011 | US20110165063 Il-1 binding proteins |
| 07/07/2011 | US20110165062 Use of an anti-cd151 antibody for early treatment of cancer |
| 07/07/2011 | CA2788450A1 Substituted naphthalenyl-pyrimidine compounds |
| 07/07/2011 | CA2786255A1 Formulations from natural products, turmeric, and aspirin |
| 07/07/2011 | CA2786090A1 Interferon analogs |
| 07/07/2011 | CA2786002A1 Tricyclic compounds for use as kinase inhibitors |
| 07/07/2011 | CA2785983A1 Sirna for inhibition of c-met expression and anticancer composition containing the same |
| 07/07/2011 | CA2785964A1 Anti-cd27 antibody |
| 07/07/2011 | CA2785898A1 Metalloenzyme inhibitor compounds |
| 07/07/2011 | CA2785749A1 Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor |